Shimadzu has been awarded a Red Dot Design Award 2021 in the product design category for its iMScope QT. It combines an LCMS-9030 Q-TOF mass spectrometry instrument with an optical microscope from the iMScope series, guaranteeing excellent speed, sensitivity and spatial resolution for data analysis. iMScope QT will soon be available for the European Market. […]
Author Archive for: panglobal
This author has yet to write their bio.
Entries by panglobal
AMSBIO, in association with Nordmark Biochemicals, is now offering animal-free Collagenase and Neutral Protease enzymes, isolated from Clostridium histolyticum, for in-vitro tissue dissociation leading to high yields of viable cells. Being animal-free, these enzymes are very safe and offer reduced regulatory hurdles for use in clinical applications. They are manufactured under GMP guidelines using a plant-based […]
Porvair Sciences has launched its new generation Ultravap Levante nitrogen blowdown sample evaporator. The second generation system offers the many benefits associated with Porvair’s flagship evaporator, the Ultravap Mistral, in an affordable, easy-to-use package. This state-of-the-art single microplate evaporator is designed to meet the current needs of most chromatography laboratories whilst providing the future option of fully automating sample dry-down […]
Researchers from Chalmers University of Technology, Sweden have developed Artificial Intelligence that is capable of generating novel, functionally active proteins. The research represents a significant breakthrough in the field of synthetic protein development. “What we are now able to demonstrate offers fantastic potential for a number of future applications, such as faster and more cost-efficient development […]
Axol Bioscience, an established provider of iPSC-derived cells, media, and characterization services, has merged with CENSO Biotechnologies, a cell biology CRO with focused expertise in iPSC-related technologies. The new entity will become a leading provider of product and service solutions in the iPSC-based neuroscience, immune cell, and cardiac modeling for drug discovery and screening markets. […]
Albumedix, a Nottingham, UK-based biotech company and world leader in recombinant human albumin (rAlb), will collaborate with the Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix’s proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
NovalGen, a biopharmaceutical company developing breakthrough cancer therapies and HALIX B.V., a contract development and manufacturing organisation, have agreed a strategic partnership wherein HALIX will manufacture clinical supplies for NovalGen’s therapies.
WuXi AppTec, a Shanghai, China-headquartered global provider of R&D- and manufacturingenabling services in the pharmaceutical, biotechnology and medical device industries, has acquired OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and […]
La Jolla Institute for Immunology (LJI), a leading research organization focussed on studying the immune system has signed a licensing agreement with Leinco Technologies, a premier developer and manufacturer of leading-edge recombinant proteins, antibodies, and conjugates. Leinco also provides custom manufacturing services to the diagnostic and biopharmaceutical industries to leverage proprietary COVID-19 antibodies developed at […]
UPM Biomedicals will collaborate with bioconvergence company CELLINK to bring together UPM’s expertise for producing non-animal derived, nanocellulose biomaterials with CELLINK’s years of experience in method development for 3D bioprinting, offering new ground-breaking solutions to this growing life sciences market.